Free Trial

C4 Therapeutics (CCCC) Institutional Ownership

C4 Therapeutics logo
$2.66 -0.07 (-2.56%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$2.67 +0.01 (+0.38%)
As of 09/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for C4 Therapeutics (NASDAQ:CCCC)

Current
Institutional Ownership
Percentage
78.81%
Number of
Institutional Buyers
(last 12 months)
63
Total
Institutional Inflows
(last 12 months)
$31.30M
Number of
Institutional Sellers
(last 12 months)
29
Total
Institutional Outflows
(last 12 months)
$11.79M
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CCCC Institutional Buying and Selling by Quarter

C4 Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Tower Research Capital LLC TRC 40,592$58K0.0%+458.0%0.057%
8/15/2025 Wasatch Advisors LP7,424,662$10.62M0.1%+10.4%10.432%
8/15/2025 Man Group plc78,487$112K0.0%-8.3%0.110%
8/15/2025 BNP Paribas Financial Markets206,177$295K0.0%+1,039.4%0.290%
8/15/2025 Bridgeway Capital Management LLC104,900$150K0.0%-19.2%0.147%
8/15/2025 Bank of America Corp DE2,008,004$2.87M0.0%+0.9%2.821%
8/15/2025 Adage Capital Partners GP L.L.C.200,000$286K0.0%-87.1%0.281%
8/14/2025 Jane Street Group LLC492,612$704K0.0%+3,816.8%0.692%
8/13/2025 Invesco Ltd.155,017$222K0.0%+11.1%0.218%
8/12/2025 XTX Topco Ltd108,278$155K0.0%+170.0%0.152%
8/12/2025 Dynamic Technology Lab Private Ltd21,476$31K0.0%N/A0.030%
8/12/2025 Catalyst Funds Management Pty Ltd28,300$40K0.0%N/A0.040%
8/8/2025 Geode Capital Management LLC745,053$1.07M0.0%-47.9%1.049%
8/6/2025 Savant Capital LLC26,347$38K0.0%N/A0.037%
8/5/2025 Crestwood Advisors Group LLC29,000$41K0.0%N/A0.041%
8/1/2025 Y Intercept Hong Kong Ltd52,521$75K0.0%N/A0.074%
7/31/2025 R Squared Ltd30,587$44K0.0%N/A0.043%
7/30/2025 Brookstone Capital Management29,325$42K0.0%N/A0.041%
6/27/2025 Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/29/2025Rhumbline Advisers89,633$143K0.0%-10.4%0.126%
5/21/2025Acadian Asset Management LLC27,675$43K0.0%N/A0.039%
5/16/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/16/2025Jacobs Levy Equity Management Inc.697,653$1.12M0.0%N/A0.983%
5/16/2025AQR Capital Management LLC140,532$225K0.0%+957.6%0.198%
5/14/2025MetLife Investment Management LLC15,893$25K0.0%-44.9%0.022%
5/13/2025American Century Companies Inc.141,986$227K0.0%+6.9%0.200%
5/12/2025Nuveen LLC192,424$308K0.0%N/A0.271%
5/12/2025Invesco Ltd.139,486$223K0.0%+101.6%0.196%
5/9/2025Deutsche Bank AG46,225$74K0.0%N/A0.065%
5/9/2025Charles Schwab Investment Management Inc.474,843$760K0.0%-2.4%0.669%
5/8/2025XTX Topco Ltd40,100$64K0.0%N/A0.056%
4/15/2025SG Americas Securities LLC425,096$680K0.0%N/A0.599%
4/10/2025Hennion & Walsh Asset Management Inc.218,411$349K0.0%-3.8%0.308%
4/8/2025Rhumbline Advisers89,633$143K0.0%-10.4%0.126%
2/18/2025Delta Investment Management LLC20,000$72K0.0%N/A0.028%
2/17/2025Soleus Capital Management L.P.6,978,942$25.12M1.6%+5.7%9.887%
2/17/2025Wexford Capital LP118,331$426K0.1%+114.2%0.168%
2/17/2025Two Sigma Investments LP563,837$2.03M0.0%-31.9%0.799%
2/17/2025Two Sigma Advisers LP884,300$3.18M0.0%-17.0%1.253%
2/17/2025Tang Capital Management LLC900,000$3.24M0.2%+28.6%1.275%
2/17/2025ProShare Advisors LLC20,283$73K0.0%+83.1%0.029%
2/17/2025Nuveen Asset Management LLC192,424$693K0.0%+6.4%0.273%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC137,360$494K0.0%+497.2%0.195%
2/17/2025Millennium Management LLC360,125$1.30M0.0%+1,548.3%0.510%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.33,675$121K0.0%-11.0%0.048%
2/17/2025Lazard Asset Management LLC22,693$81K0.0%N/A0.032%
2/17/2025D. E. Shaw & Co. Inc.76,479$275K0.0%-35.7%0.108%
2/17/2025Cubist Systematic Strategies LLC109,825$395K0.0%+6.6%0.156%
2/17/2025Balyasny Asset Management L.P.42,533$153K0.0%+115.4%0.060%
2/17/2025Bank of America Corp DE1,677,642$6.04M0.0%-17.6%2.377%
2/17/2025ArrowMark Colorado Holdings LLC1,334,101$4.80M0.1%+1.1%1.890%
2/14/2025Jane Street Group LLC152,774$550K0.0%+49.4%0.216%
2/14/2025Northern Trust Corp495,043$1.78M0.0%+1.1%0.701%
2/14/2025The Manufacturers Life Insurance Company21,573$78K0.0%-48.2%0.031%
2/14/2025Lynx1 Capital Management LP6,852,744$24.67M9.2%-0.4%9.708%
2/14/2025Susquehanna Fundamental Investments LLC108,664$391K0.0%N/A0.154%
2/14/2025Adage Capital Partners GP L.L.C.1,550,000$5.58M0.0%+198.1%2.196%
2/14/2025Price T Rowe Associates Inc. MD38,143$138K0.0%-90.3%0.054%
2/14/2025Silverarc Capital Management LLC1,221,131$4.40M1.0%-5.9%1.730%
2/14/2025Stifel Financial Corp13,361$48K0.0%-53.0%0.019%
2/14/2025Tower Research Capital LLC TRC10,974$40K0.0%-53.7%0.016%
2/14/2025MetLife Investment Management LLC28,854$104K0.0%-18.6%0.041%
2/14/2025Dimensional Fund Advisors LP523,931$1.89M0.0%-9.5%0.742%
2/13/2025Marshall Wace LLP36,167$130K0.0%-84.0%0.051%
2/13/2025Wasatch Advisors LP6,072,601$21.86M0.1%+7.0%8.603%
2/13/2025Mariner LLC167,975$605K0.0%+28.8%0.238%
2/13/2025Barclays PLC122,365$441K0.0%-49.7%0.173%
2/13/2025Invesco Ltd.69,193$249K0.0%+7.2%0.098%
2/13/2025Bank of Montreal Can24,450$88K0.0%-54.8%0.035%
2/13/2025Wells Fargo & Company MN36,306$131K0.0%+34.9%0.051%
2/12/2025ExodusPoint Capital Management LP59,654$215K0.0%N/A0.085%
2/12/2025Geode Capital Management LLC1,381,086$4.97M0.0%+0.8%1.957%
2/12/2025JPMorgan Chase & Co.33,409$120K0.0%+29.6%0.047%
2/11/2025LPL Financial LLC70,325$253K0.0%+13.1%0.100%
2/11/2025Sei Investments Co.12,399$45K0.0%N/A0.018%
2/11/2025American Century Companies Inc.132,832$478K0.0%+8.5%0.188%
2/11/2025Kazazian Asset Management LLC14,250$51K0.0%N/A0.020%
2/11/2025Intech Investment Management LLC30,150$109K0.0%+11.1%0.043%
2/10/2025Commonwealth Equity Services LLC28,880$104K0.0%-17.9%0.041%
2/6/2025M&T Bank Corp132,715$478K0.0%+16.5%0.188%
2/6/2025Charles Schwab Investment Management Inc.486,366$1.75M0.0%+0.7%0.689%
2/4/2025Y Intercept Hong Kong Ltd23,176$83K0.0%N/A0.033%
1/30/2025Rhumbline Advisers100,015$360K0.0%+4.6%0.142%
1/24/2025China Universal Asset Management Co. Ltd.14,967$54K0.0%N/A0.021%
1/15/2025Hennion & Walsh Asset Management Inc.227,147$818K0.0%+18.1%0.322%
11/27/2024Franklin Resources Inc.34,383$202K0.0%N/A0.049%
11/19/2024Barclays PLC243,457$1.39M0.0%+38.4%0.345%
11/18/2024Arete Wealth Advisors LLC73,350$418K0.0%-34.1%0.104%
11/16/2024Geode Capital Management LLC1,369,676$7.81M0.0%+0.5%1.940%
11/15/2024Vestcor Inc29,500$168K0.0%N/A0.042%
11/15/2024M&T Bank Corp113,907$649K0.0%+19.3%0.161%
11/15/2024Barclays PLC243,457$1.39M0.0%+38.4%0.345%
11/15/2024XTX Topco Ltd84,951$484K0.0%N/A0.120%
11/15/2024Wellington Management Group LLP286,041$1.63M0.0%+24.7%0.405%
11/15/2024Wexford Capital LP55,231$315K0.1%N/A0.078%
11/15/2024State Street Corp2,806,913$16.00M0.0%-6.3%3.976%
11/15/2024Point72 DIFC Ltd8,873$51K0.0%N/A0.013%
11/15/2024Point72 Asset Management L.P.1,201,848$6.85M0.0%+331.4%1.703%
11/15/2024ArrowMark Colorado Holdings LLC1,319,484$7.52M0.1%+6.0%1.869%
11/14/2024Wasatch Advisors LP5,677,368$32.36M0.2%+17.1%8.043%
(Data available from 1/1/2016 forward)

CCCC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CCCC shares?

During the previous two years, 107 institutional investors and hedge funds held shares of C4 Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($25.12M), Lynx1 Capital Management LP ($24.67M), Vanguard Group Inc. ($23.86M), Commodore Capital LP ($21.47M), State Street Corp ($16.00M), Wasatch Advisors LP ($10.62M), and Bain Capital Life Sciences Investors LLC ($9.33M).Learn more on C4 Therapeutics' institutional investors.

What percentage of C4 Therapeutics' stock is owned by institutional investors?

78.81% of C4 Therapeutics' stock is owned by institutional investors. Learn more on CCCC's institutional investor holdings.

Which institutional investors have been buying C4 Therapeutics' stock?

Of the 82 institutional investors that purchased C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynx1 Capital Management LP ($4.77M), Commodore Capital LP ($3.80M), Wasatch Advisors LP ($2.82M), Adage Capital Partners GP L.L.C. ($1.03M), Point72 Asset Management L.P. ($923.27K), Vanguard Group Inc. ($920.63K), and Jacobs Levy Equity Management Inc. ($697.65K).

How much institutional buying is happening at C4 Therapeutics?

Institutional investors have bought a total of 9,157,489 shares in the last 24 months. This purchase volume represents approximately $31.30M in transactions.

Which of C4 Therapeutics' major shareholders have been selling company stock?

Of the 29 institutional investors that sold C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.35M), Geode Capital Management LLC ($685.24K), Bank of America Corp DE ($358.59K), Price T Rowe Associates Inc. MD ($353.86K), Two Sigma Investments LP ($264.65K), Cubist Systematic Strategies LLC ($203.90K), and Marshall Wace LLP ($189.25K).

How much institutional selling is happening at C4 Therapeutics?

Institutional investors have sold a total of 4,345,581 shares in the last 24 months. This volume of shares sold represents approximately $11.79M in transactions.



This page (NASDAQ:CCCC) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners